SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-298850
Filing Date
2014-08-07
Accepted
2014-08-06 20:40:26
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d745229d10q.htm 10-Q 519529
2 EX-31.1 d745229dex311.htm EX-31.1 6748
3 EX-31.2 d745229dex312.htm EX-31.2 6742
4 EX-32.1 d745229dex321.htm EX-32.1 4070
5 EX-32.2 d745229dex322.htm EX-32.2 4069
  Complete submission text file 0001193125-14-298850.txt   3787987

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vtl-20140630.xml EX-101.INS 486269
7 XBRL TAXONOMY EXTENSION SCHEMA vtl-20140630.xsd EX-101.SCH 37634
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtl-20140630_cal.xml EX-101.CAL 47164
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtl-20140630_def.xml EX-101.DEF 132249
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtl-20140630_lab.xml EX-101.LAB 333503
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtl-20140630_pre.xml EX-101.PRE 231652
Mailing Address 15222 AVENUE OF SCIENCE, SUITE B SAN DIEGO CA 92128
Business Address 15222 AVENUE OF SCIENCE, SUITE B SAN DIEGO CA 92128 858-673-6840
VITAL THERAPIES INC (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36201 | Film No.: 141021446
SIC: 2834 Pharmaceutical Preparations